LOGIN
IV TXA Reduces Blood Loss and Transfusion Need in Intertrochanteric Fracture Surgery using PFNA
September 2019
IV TXA Reduces Blood Loss and Transfusion Need in Intertrochanteric Fracture Surgery using PFNA
Study Type:Randomized Trial
OE Level Evidence:2
Journal Level of Evidence:N/A
Efficacy and Safety of Tranexamic Acid in Intertrochanteric Fractures: A Single-Blind Randomized Controlled Trial
Orthop Surg. 2019 Aug;11(4):635-642.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
One hundred patients scheduled for surgical treatment of an intertrochanteric fracture with a proximal femoral nail anti-rotation system were randomized to receive tranexamic acid (TXA) or no treatment for the reduction of blood loss and need for transfusion. The primary outcome of interest was estimated total blood loss. Additional outcomes of interest included intra-operative and hidden blood lo...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.